Fountainhead Venture Group
Fountainhead Venture Group
is a Philadelphia-based investment partnership that makes early- to mid-stage
venture capital investments at the intersection of health care, life sciences,
and information technology. We look for
companies providing technology-based products and services or
technology-enabled new business models to health care payers and providers or
to the pharmaceutical and life sciences industries.
Fountainhead was founded
by Tom Olenzak, John Braca, and Frank Lexa, all experienced health care venture
capitalists. Tom founded and ran the
First Ventures Healthcare and Life Sciences Investment Fund, LLC, a corporate
venture fund formed by First Consulting Group, Inc. (Nasdaq: FCGI) to invest in
emerging health care and life sciences technology companies. John was most recently a General Partner of
S.R. One, the venture capital arm of GlaxoSmithKline, and was a partner and founder
of EuclidSR investments. Frank is a
practicing physician and a professor with both the School of Medicine and the
Wharton School at the University of Pennsylvania, and was a partner with
Philadelphia Ventures.
Investment areas of
specific interest to Fountainhead include:
We look for companies that
have a:
Fountainhead brings deep
domain expertise and strong financial and operating experience to its
investments. The Fountainhead managers
understand how to identify those health care technology companies that have the
potential to achieve significant scale; they help those companies grow in the
competitive, changing, and regulated health care environment; and work with their
managers to create meaningful value-creating liquidity events.
For direct inquiries or to
submit a business plan contact:
Fountainhead Venture
Group Management, L.P.
Telephone: (610) 415-1240
Fax:
(610) 983-9376
|
Tom Olenzak Managing Director tolenzak@fountainheadventure.com |
John Braca Managing Director jbraca@fountainheadventure.com |
|
Frank Lexa Managing Director flexa@fountainheadventure.com |